BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22429890)

  • 1. Transdermal iontophoresis of ranitidine: an opportunity in paediatric drug therapy.
    Djabri A; Guy RH; Delgado-Charro MB
    Int J Pharm; 2012 Oct; 435(1):27-32. PubMed ID: 22429890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the cutaneous iontophoretic delivery of rasagiline and selegiline across porcine and human skin in vitro.
    Kalaria DR; Patel P; Patravale V; Kalia YN
    Int J Pharm; 2012 Nov; 438(1-2):202-8. PubMed ID: 22954444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl.
    Silva SM; Hu L; Sousa JJ; Pais AA; Michniak-Kohn BB
    Eur J Pharm Biopharm; 2012 Apr; 80(3):663-73. PubMed ID: 22137964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo transdermal iontophoretic delivery of naloxone, an opioid antagonist.
    Yamamoto R; Takasuga S; Yoshida Y; Mafune S; Kominami K; Sutoh C; Kato Y; Yamauchi M; Ito M; Kanamura K; Kinoshita M
    Int J Pharm; 2012 Jan; 422(1-2):132-8. PubMed ID: 22108639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive and iontophoretic transdermal delivery of phenobarbital: Implications in paediatric therapy.
    Djabri A; Guy RH; Delgado-Charro MB
    Int J Pharm; 2012 Oct; 435(1):76-82. PubMed ID: 22387370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal iontophoretic delivery of selegiline hydrochloride, in vitro.
    Kolli CS; Chadha G; Xiao J; Parsons DL; Babu RJ
    J Drug Target; 2010 Nov; 18(9):657-64. PubMed ID: 20038213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal iontophoretic delivery of terbinafine hydrochloride: quantitation of drug levels in stratum corneum and underlying skin.
    Sachdeva V; Siddoju S; Yu YY; Kim HD; Friden PM; Banga AK
    Int J Pharm; 2010 Mar; 388(1-2):24-31. PubMed ID: 20025950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
    Nair A; Vyas H; Shah J; Kumar A
    Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of constant current alternating current iontophoresis for transdermal drug delivery.
    Yan G; Li SK; Higuchi WI
    J Control Release; 2005 Dec; 110(1):141-50. PubMed ID: 16289410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled delivery of ropinirole hydrochloride through skin using modulated iontophoresis and microneedles.
    Singh ND; Banga AK
    J Drug Target; 2013 May; 21(4):354-66. PubMed ID: 23311703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal absorption of memantin--effect of chemical enhancers, iontophoresis, and role of enhancer lipophilicity.
    del Rio-Sancho S; Serna-Jiménez CE; Calatayud-Pascual MA; Balaguer-Fernández C; Femenía-Font A; Merino V; López-Castellano A
    Eur J Pharm Biopharm; 2012 Sep; 82(1):164-70. PubMed ID: 22732268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo.
    Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN
    Eur J Pharm Biopharm; 2014 Sep; 88(1):56-63. PubMed ID: 24525072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microneedle assisted iontophoretic transdermal delivery of prochlorperazine edisylate.
    Kolli CS; Xiao J; Parsons DL; Babu RJ
    Drug Dev Ind Pharm; 2012 May; 38(5):571-6. PubMed ID: 21980925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iontophoretic delivery of ropinirole hydrochloride: effect of current density and vehicle formulation.
    Luzardo-Alvarez A; Delgado-Charro MB; Blanco-Méndez J
    Pharm Res; 2001 Dec; 18(12):1714-20. PubMed ID: 11785691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal drug delivery using microemulsion and aqueous systems: influence of skin storage conditions on the in vitro permeability of diclofenac from aqueous vehicle systems.
    Sintov AC; Botner S
    Int J Pharm; 2006 Mar; 311(1-2):55-62. PubMed ID: 16431047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of iontophoresis on in vitro transdermal absorption of almotriptan.
    Calatayud-Pascual MA; Balaguer-Fernández C; Serna-Jiménez CE; Del Rio-Sancho S; Femenía-Font A; Merino V; López-Castellano A
    Int J Pharm; 2011 Sep; 416(1):189-94. PubMed ID: 21736929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrically enhanced transdermal delivery of a macromolecule.
    Badkar AV; Banga AK
    J Pharm Pharmacol; 2002 Jul; 54(7):907-12. PubMed ID: 12162708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulated iontophoretic delivery of small and large molecules through microchannels.
    Kumar V; Banga AK
    Int J Pharm; 2012 Sep; 434(1-2):106-14. PubMed ID: 22633929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.